Latest filing published 14 Aug 2026 for Krystal Biotech, Inc.. Read the official filing
Dino A. Rossi discloses dealings in Krystal Biotech, Inc. to SEC (Form 4). Over a trading history stretching from 1 March 2023 to 14 August 2026, the count stands at 12 filings.
No open-market purchase appears, only 9 sales worth €10.3M. Outside the open market, there are 1 option exercise. Since January 2026: no purchases and 8 sales on the market.
On 14 August 2026 came the latest disclosure, a transaction in Krystal Biotech, Inc. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
12 of 12 declarations